Chapter 47: Eye & Ear Disorder Drug Therapy

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

You know, when we look at the nursing curriculum, there are chapters that just, they scream emergency right off the bat.

Like cardiac arrest, respiratory failure.

Exactly.

Shock.

Those are the chapters where the adrenaline, you know, it starts pumping just from reading the table of contents.

And then, then there are chapters like the one we are covering today, eye and ear disorders.

Right.

The chapters of people, they tend to skim, they look at and think, okay, eye drops and earwax.

Yeah.

How hard can this be?

Yes.

It feels, well, peripheral,

pun intended, I guess.

But looking at chapter 47 from the pharmacology, a patient centered nursing process approach I realized we are dealing with some of the most deceptively dangerous territory in medicine.

It really is.

It's not just about helping someone see a bit better.

No, it's about systemic safety, the whole body.

It is the small anatomy, massive consequence paradox.

You're dealing with structures, the eye specifically, that are essentially pressurized closed systems.

And they're connected directly to the brain.

Directly to the brain.

And the margin for error, it's microscopic, literally.

And that's our mission for this Deep Dive.

We're not just going to sit here and memorize a list of drops.

We need to understand how a tiny drop of Timalol in the eye can, and I'm not exaggerating, stop a patient's heart.

Or how treating a simple viral infection with the wrong anti -inflammatory, something that seems intuitive, can cost a patient their vision.

Or how a simple over -the -counter decongestant for a stuffy nose could potentially blind a patient with a specific type of glaucoma.

These are the stakes.

They are incredibly high.

That is a terrifying thought to kick us off.

So we are going to act as the ultimate study companion today.

We're going to slow this down.

We'll map out the plumbing of the eye, look at the terrifying mechanics of the glaucoma.

And then, and this is the big one, we're going to deconstruct the drugs.

And my focus is going to be purely on clinical judgment.

I don't want you to just know what the drug is.

I want you to know what to think when you're holding that little bottle at the bedside.

Okay, let's start with the architecture.

Section 1.

The eye anatomy and physiology breakdown.

The text breaks the eye down into three layers.

And I think for pharmacology, we have to look at these not just as anatomical features.

No, you have to see them as drug targets.

That's the right way to see it.

If you don't understand the layers, you won't get why some drugs can get in and others just can't.

So the outer layer is your shield.

It's the fibrous layer.

You've got the sclera.

That's the white part.

Right, the tough outer shell.

And the cornea, the clear window at the front.

The cornea is interesting because the text makes a very specific point about it being a vascular.

No blood vessels.

Which is a huge deal for drug delivery.

I mean, think about it.

If you take a pill, an oral antibiotic for, say, a skin infection, it travels through your blood to get to the infection.

Sure, that makes sense.

But the cornea has no blood supply.

It gets its nutrients from the fluid inside the eye, the aqueous humor, and it gets its oxygen directly from the air.

So wait, if I have a corneal infection, just popping an oral antibiotic might not really work all that well?

It's going to struggle.

It will struggle to reach therapeutic levels right there on the cornea.

That's why topical application, you know, drops and ointments is king in ophthalmology.

You have to put the drug directly on the tissue.

But that lack of blood supply, it also makes it vulnerable, doesn't it?

It can't just call in the cavalry of white blood cells easily.

Exactly.

It's what we call an immunologically privileged site.

But that's a double -edged sword.

It means infections can take hold fast.

And because it relies on that internal fluid for its health, if the pressure inside the eye goes up, the intraocular pressure or IOP, right, if the IOP rises,

the cornea can actually lose its transparency.

You can get cloudy.

Then you have the sclera, which is that opaque white fibers and envelope.

That's the structure.

The tough part.

OK, so that's the protective outer layer.

Let's move one layer deeper, the vascular layer.

The text calls it the uvea.

This feels like the engine room of the eye.

It is.

This includes the choroid, the ciliary body, and the iris.

The choroid is rich in blood vessels, and it absorbs light, prevents it from scattering.

The iris, which gives the eye its color, is actually a muscle structure that surrounds the pupil.

And its whole job is light control.

Right.

It dilates and constricts to control exactly how much light gets to hit the lens and the retina.

But for our pharmacology discussion today,

the real MVP, or maybe the villain,

is the ciliary body.

The ciliary body.

This is where all the trouble on glaucoma starts, right?

Pretty much.

Because it's the faucet.

It is constantly pumping out a fluid called aqueous humor.

And this isn't just water.

It's a carefully balanced, nutritive fluid that, among other things, keeps that vascular cornea alive.

OK, so it's making the fluid.

And it also supports the lens for accommodation.

That's the process of focusing on objects near and far.

So we have the shield, which is the cornea.

We have the engine room, the uvea, and finally, layer three.

That is the sensory layer, the retina.

This is where the magic really happens.

It contains the rods and cones, the photoreceptors that convert light into nerve impulses.

And those impulses travel down the optic nerves straight to the brain.

And that's how we see.

It's an electrical signal.

OK, so we have protection, vascular control, and sensory.

Now, let's talk about those fluid dynamics.

The text makes it absolutely clear that you cannot understand glaucoma if you don't understand fluid flow.

You called the ciliary body the faucet.

Where does the water go?

OK, so think of the eye's anterior chamber, that's the space in front of the lens, as a sink.

The faucet is the ciliary body.

And it's constantly on, constantly producing this clear fluid.

Now, in any functioning sink, you need a drain to prevent it from overflowing.

Makes sense.

So where is the drain in the eye?

The primary drain is a delicate, spongy structure called the trabecular meshwork.

It's located in the angle where the cornea and the iris meet.

The fluid flows through this meshwork and then exits the eye via the canalish limb.

So that's the main exit.

It's the main one.

There's also a smaller amount of fluid, about 10%, that exits through what's called the uveous -chloral pathway at the root of the iris.

But for understanding glaucoma, that trabecular meshwork is the key player.

So if the faucet is running, that's production by the ciliary body, and the drain is open, the trabecular meshwork, the pressure inside the eye stays normal.

Precisely.

The system is in balance.

But if fluid production exceeds drainage,

and that's usually because the drain is clogged, then intraocular pressure, or IOP, starts to rise.

And since the eye is a closed sphere, it can't expand like a balloon.

It can't.

So that pressure has nowhere to go but to push backwards.

Pushing against the retina and, crucially, the optic nerve head.

And that pressure physically damages the optic nerve fibers.

It crushes them over time.

That is the mechanism of glaucoma.

It is, at its heart, a plumbing problem that leads to permanent nerve damage and blindness.

That is a fantastic setup.

So before we get to the grugs that try to fix the plumbing, let's look at the disorders themselves in section two.

The text starts with something a bit more common, maybe less permanent.

Infections and inflammation.

Right.

The most common one everyone knows is conjunctivitis, or pink eye.

It's an inflammation of the conjunctiva, that thin membrane covering the white of the eye and the inner eyelids.

It can be caused by allergens, viruses, or bacteria.

But the text lists a whole host of other infections with names that, honestly, sound like spells from Harry Potter.

Blepharitis.

Blepharitis is an infection of the margins of the eyelid.

It's often chronic, really annoying for patients with crusting and irritation.

Then you have a chalazian.

This is an infection of the myobomian glands.

Those are the glands in the eyelids that make oil, right?

Exactly.

They produce the oily layer of your tears to keep them from evaporating too quickly.

If one of those glands gets infected and blocked, it can actually form a cyst.

And a hordeolum.

That is the medical term for a stye.

It's just a local infection of an eyelash follicle, usually right on the edge of the lid.

Okay.

Those sound painful, but usually manageable.

The text mentions some really severe ones, though.

And nophthalmitis.

Now, that is very serious.

That's an infection and inflammation of the structures of the inner eye.

The vitreous, the retina, it can threaten vision entirely and often requires aggressive treatment, sometimes injections right into the eye.

And infectious keratitis.

A corneal infection.

And remember what we said, the cornea is vulnerable.

If that gets infected, it can lead to scarring.

And if the scar is in your central vision, it can be devastating.

Okay.

Moving from infections to something that affects the aging population so significantly.

Age -related macular degeneration, or AMD.

The text distinguishes between two types.

Help us understand the difference between dry and wet AMD, because the treatments are worlds apart.

This is a crucial distinction.

AMD affects the macula, which is the tiny central part of the retina responsible for sharp, detailed central vision.

So reading, recognizing faces, driving.

All of that.

Losing the macula means losing your functional independence in many cases.

Let's start with dry AMD.

Dry AMD is by far the most common form, maybe 85 to 90 % of cases.

It happens slowly.

It's caused by the deposit of this extracellular material, basically cellular waste products, called drusen, under the retina.

Drusen?

Sounds kind of dusty.

It kind of is.

Imagine little yellow piles of debris accumulating.

Along with these deposits, the retina itself thins out atrophies and stops functioning properly.

It progresses over years.

And right now, we don't really have a cure for this.

It's more about slowing it down.

Exactly.

Prevention strategies are key.

Now compare that to wet AMD.

Wet or neovascular, AMD is much more aggressive.

Neovascular means new vessels.

What happens is that abnormal blood vessels start to grow from the layer beneath the retina, the choroid.

But new blood vessels sound like a good thing.

Not these.

They are weak,

fragile, and leaky.

They leak fluid and blood, which collects behind the retina and physically displaces the macula distorting vision.

Straight lines can look wavy.

That sounds incredibly destructive.

It is.

It only accounts for about 10 to 15 % of AMD cases.

But it is responsible for the vast majority, like 80%, of severe legal blindness from AMD.

And it happens fast.

A patient's vision can decline dramatically in weeks or months.

So dry is slow and involves deposits.

Wet is fast and involves leaky blood vessels.

Okay, now let's go back to that plumbing problem, glaucoma.

The text breaks this down into open angle and angle closure.

And this is probably the single most important distinction for a nurse to understand, especially when it comes to medication safety.

Let's go back to our sync analogy.

Okay, I'm ready.

In open angle glaucoma, the angle refers to that angle between the iris and the cornea where the trabecular meshwork is located.

In this type, the door to the drain is wide open.

You can walk right up to the drainpipe.

Okay, so access isn't the problem.

No, the problem is the pipe itself.

The trabecular meshwork is clogged with gunk.

It's not filtering properly.

It's like a kitchen sink drain that's gotten slow over years from grease and food particles.

So the sink is accessible, but the pipe is stuffed up.

The water backs up slowly.

Pressure builds up gradually, insidiously over time.

This is the most common type.

It's chronic.

Patients often don't even know they have it until they've lost a significant amount of peripheral vision.

Now compare that to angle closure or narrow angle glaucoma.

In this scenario, the pipe might be perfectly clean.

The problem is the anatomy.

The iris is situated too close to the drainage angle.

It's physically blocking the entrance to the trabecular network.

Like putting a rubber stopper in the sink drain.

Exactly.

And if that angle closes completely, if the iris pushes up against it and seals it off, the fluid has nowhere to go.

Pressure spikes dramatically and quickly.

This is a medical emergency.

An absolute medical emergency.

The patient will have sudden blurred vision, see halos around lights, and have severe eye pain, maybe nausea and vomiting.

If you don't treat it immediately to lower the pressure, permanent blindness can occur within a day or two.

The text has a specific, and I mean really highlighted, warning here about drugs and angle closure glaucoma.

Yes.

This is a critical, must -know nursing consideration.

Any drug that causes the pupil to dilate a process called midriasis can trigger an acute angle closure attack in a susceptible patient.

So why does dilating the pupil cause the angle to close?

I'm trying to picture that.

Think about the mechanics.

The iris is like a soft, flexible curtain.

When the pupil dilates, that curtain has to bunch up.

Like when you open a drawstring bag, the fabric gathers at the top.

Okay, I see that.

If a patient already has a narrow angle, that bunched -up iris tissue can thicken enough to completely press against the cornea and block off the drainage angle.

It closes the door to the drain.

That is a brilliant visual.

So if a patient has a known history of narrow angle glaucoma, or even if we just know they have a predisposition to it, we absolutely want to avoid dilating their pupils.

Correct.

And that includes not just ophthalmic eye drops, but also systemic drugs that have anti -cholinergic side effects, which can cause pupil dilation.

The text specifically warns that common decongestants, and even certain herbal preparations like goldenseal, ephedra, and bitter orange, can increase that risk.

Okay, let's unpack the drugs themselves.

Section three, general ophthalmic drugs.

The text starts with a really practical but vital point about administration safety.

It seems so basic, but it's where so many errors happen.

Sterility is paramount.

You never, ever, ever touch the tip of the dropper to the eye, to your finger, to the eyelid, to anything.

Because if that bottle gets contaminated...

You are introducing bacteria directly onto that vulnerable cornea we talked about earlier.

You could cause a serious infection.

And what about contact lenses?

What's the rule there?

Generally, wearing contact lenses is discouraged during treatment with most eye drops.

But if a patient must wear them, the rule is to wait at least 15 minutes after instilling the drops before reinserting the contacts.

Why is that?

What's the mechanism?

The soft lenses can absorb the medication and the preservative in it like a sponge.

This can either damage the lens itself, or worse, it can slowly release a concentrated dose of the drug over a long period, which could cause toxicity to the cornea.

Okay, let's talk about diagnostic drugs.

I've always been fascinated by the stains they use.

Fluorescent sodium.

Yes.

It's an amazing diagnostic tool.

It's used to visualize the anterior ocular surface, basically to look for defects.

You put the drop in, and then you look at the eye under a special cobalt blue filter light.

And what do you see?

Any corneal scratch, abrasion or lesion, will pool the dye and fluoresce a brilliant, almost neon yellow -green.

It's like using a highlighter pen to mark eye damage.

That's very cool.

Then you have topical anesthetics like proparacane or tetracane.

These are used to numb the eye for exams or for procedures like removing a foreign body.

They work incredibly fast within 15 seconds.

Yeah, and last for about 15 minutes.

But there's a really important nursing insight here regarding the blink reflex.

Right.

When the eye is numb, the natural blink reflex is temporarily lost.

The corneal surface can become dry, but more importantly, the patient must be instructed very clearly not to rub, touch or wipe the affected eye.

Because they could scratch it and not even know.

They could scratch the cornea badly and not feel a thing until the anesthesia wears off.

And then they are in a world of pain.

We have to protect that eye for them while it's numb.

Moving on to anti -infectives.

We have a lot of options here.

For bacterial conjunctivitis, we see a lot of familiar names.

Supraflaxicin, gentamicin, tobrilicin.

These are your standard workhorse antibacterials.

But there are specific nuances to be aware of.

For instance, gentamicin has a black box warning about ototoxicity ear damage.

So we have to be extremely careful if we are dealing with a perforated eardrum, which we will get to later.

In the eye, it can cause local irritation.

Then there is natamycin.

This is an antifungal.

The text has a weird but important alert here.

It's used for fungal infections of the cornea or eyelids.

But the alert is that patients who are allergic to cheese might have a sensitivity to natamycin.

Allergic to cheese.

That is definitely going in my surprising facts column.

Why on earth is that?

It's thought to have to do with the antigens found in the mold used to produce certain cheeses, like blue cheese, being structurally similar to the finger targets of the drug.

It's rare.

But if a patient lists Roper cheese as an allergy, you need to stop and think.

And for viral infections like herpes simplex keratitis, we use trifluridine.

But there is a huge warning here regarding the use of corticosteroids.

This is massive.

It's a fundamental rule of ophthalmology.

Never ever use corticosteroids for a suspected viral infection unless you are specifically covering it with an effective antiviral at the same time.

What do the steroids do?

Steroids suppress the immune response.

That's their job.

If you suppress the immune system while a virus like herpes is actively attacking the cornea, you've just taken away the body's defenses.

The virus will replicate unchecked.

It can lead to a geographic ulcer, corneal melting, and even perforation of the eye.

That is horrifying.

Speaking of new drugs, the text highlights a 2023 approval.

Lord -o -leaner.

Yes, this is for Demodex blepharitis.

Demodex are these tiny parasitic mites that live in our eyelash follicles.

Mites in the eyelashes.

I'm going to try not to think about that too much for the rest of the day.

It's actually incredibly common.

Most of us have them.

But sometimes they overgrow and cause an infestation that leads to blepharitis.

Lord -o -leaner is a new treatment.

It's a six -week course of drops that essentially paralyzes and kills the mites.

Let's talk about anti -inflammatories.

We have NSAIDs and corticosteroids.

Why choose one over the other?

NSAIDs, like declofenac or keterolac, are often used post -surgically to reduce inflammation and pain.

They work by preventing the formation of prostaglandins.

A key side effect you have to watch for is that they can increase bleeding tendencies in the eye and potentially delay corneal healing.

And corticosteroids, like dexamethasone or prednisolone.

These are much more potent, but they carry much higher risks.

As we just mentioned, they can mask or worsen infections.

But specifically for glaucoma, and this is a big one, prolonged use of corticosteroids can reduce the outflow of aqueous humor and actually cause glaucoma.

So it clogs the drain.

It clogs the drain.

It's called steroid -induced glaucoma.

So if a patient is on long -term steroid drops for any reason, we absolutely need to be monitoring their eye pressure regularly.

That's a critical point.

The effects are usually reversible once you stop the steroid, but you have to catch it before significant nerve damage happens.

There is also a class called immunomodulators, and the text highlights cyclosporine.

This is for dry eye.

Right, or xerophelmia.

This isn't just about adding water with artificial tears.

This condition often involves inflammation, where the body's own T lymphocytes damage the lacrimal gland, the tear -producing gland.

So it's an autoimmune component.

Exactly.

Cyclosporine is an immunosuppressant.

It suppresses those T cells, which reduces the inflammation and allows the lacrimal gland to start producing tears again.

That's very different from just using artificial tears, which are basically just lubricants.

Correct.

Although speaking of lubricants, there is another new 2023 drug mentioned, perfluorhexyloctane.

It's a completely new mechanism.

It's a semi -fluorinated alkane that reduces tear evaporation at the surface of the eye.

It creates this tiny lipid shield to keep the moisture in.

Now, the text mentions decongestants for the eye phenoliphrine, naphthalene.

These are the get -the -red -out drops.

They do, and they work via vasoconstriction.

They stimulate alpha -adrenergic receptors in the arterioles of the conjunctiva, clamping down on those tiny vessels to make the eye look white.

But again, there's a warning.

Always a warning.

Systemic absorption can cause a rise in blood pressure.

And because they have sympathetic effects, they can cause some pupil dilation, which makes them dangerous for patients at risk for angle closure glaucoma.

Okay, the last group in this general section.

Medriatics and cycloplegics.

These are the drops used to prepare for eye exams or surgery.

Right.

Medriatics dilate the pupil.

That's mydriasis.

Cycloplegics paralyze the muscle of accommodation.

That's cycloplegia, meaning the lens can't focus.

The most common class here is the anticholinergics, like atropine or trophomide.

We touched on this with the bunching up of the iris, but what about systemic toxicity?

Anticholinergic toxicity is a very real systemic risk.

If too much of the drug gets absorbed, you get the classic signs.

The text quotes the old mnemonic, mad as a hatter,

which refers to psychosis and confusion.

Red as a beet.

Flushing of the skin,

dry as a bone, dry mouth, dry skin.

Blind as a bat, which is the blurred vision from the cycloplegia.

And hot as a hare, hyperthermia or fever.

And I can't stress this enough.

These are absolutely contraindicated in patients with angle closure glaucoma.

Strictly, because that paralyzed bunched up iris will definitely block the outlet for aqueous humor flow and spike the pressure.

Let's move to section four, advanced treatments.

This cover is AMD and gene therapy.

For dry AMD, you said prevention is really the only strategy we have.

Yes.

At this time, there is no known treatment or medication to cure dry AMD.

We rely on things like the ARD -SU formula of antioxidants.

Vitamin C, E, zinc, and a diet rich in dark, leaky greens and yellow fruits.

Things with lutein and zexanthin.

The goal is just to slow the progression of those drusen deposits.

But for wet AMD, we have these powerful drugs called VEGF inhibitors, ranvizumab, a flavor step.

How do they work?

VEGF stands for vascular endothelial growth factor.

It's the signaling protein in the body that tells it to grow those new, leaky blood vessels behind the retina.

These drugs are monoclonal antibodies that inhibit VEGF.

They essentially turn off the growth signal.

And how are they administered?

Because this is the part patients often struggle with.

It is.

They are given by intravitreal injection.

That means a shot with a very fine needle directly into the vitreous humor, the jelly of the eye.

Wow.

It sounds absolutely frightening, I know, but it is a sight saving procedure.

However, sticking a needle in the eye is not without risks.

And dophthalmitis, which is that severe inner eye infection, retinal detachment, or temporary increase in IOP.

The text mentions another new drug here, approved in 2023, Avacynkeptide Pagel.

Yes.

This is a C5 inhibitor for something called geographic atrophy, which is an advanced form of dry AMD.

It works on the complement system, a part of the immune system to prevent cell damage and death in the retina.

It's another new angle of attack.

And then gene therapy.

This really feels like science fiction.

Vortigine parvovac urzol.

It is incredible.

This is for a specific type of inherited retinal dystrophy caused by a mutation in a gene called

RPE65.

It uses a modified harmless viral vector to deliver a normal copy of that gene directly to the retinal cells.

And it can actually restore vision.

It can restore the visual cycle in patients who were previously going blind from this genetic defect.

It's a one -time treatment, and it's truly revolutionary.

That is amazing progress.

Okay, let's get to the heavyweight division.

Section 5, glaucoma and ocular hypertension drugs.

We have a lot of classes here.

The goal for all of them is simple, decrease intraocular pressure.

Right.

And you have two main levers to pull.

You can either turn down the faucet, which means decrease the production of aqueous humor, or you can unclog the drain, which means increase the outflow of aqueous humor.

Let's start with class one, crosticlandin analogs, latoprost, bimatoprost.

The text says these are often first -line therapy.

They are.

They are very effective and usually well tolerated.

They act on the drainage side of the equation.

They work by improving outflow through the trabecular mesh work and, importantly, increasing flow through that secondary uveous clural pathway.

They are usually just taken once a day at bedtime.

But the side effects are, well, they're unique.

They are very unique, and nurses absolutely need to warn patients about the cosmetic changes.

The most significant one is that they can cause a permanent darkening, a browning, of the iris.

If you have blue eyes, they stay blue, but if you have green -brown or yellow -brown eyes, the brown pigment increases.

And that change is permanent.

It is.

They can also darken the eyelid skin, which is usually reversible.

And of course, the famous side effect, the eyelashes.

Yes, hypertrichosis, a growth in the number, length, thickness, and darkness of the eyelashes.

Bimatoprost is actually marketed under the brand name Lattice, specifically for cosmetic lash growth.

But as a glaucoma drug, if you only treat one eye, you might end up with one eye having these luscious long lashes and the other being normal, which can look a bit odd.

OK, class two, cholinergic agents,

palocarpine.

These are the meiotics.

They cause meiosis, which is constriction of the pupil.

They make the pupil very small.

So how does shrinking the pupil help with glaucoma?

Remember that visual of the iris bunching up when it dilates and blocking the drain?

Well, constricting the pupil does the exact opposite.

It pulls the iris tissue taut and straight, like pulling a sheet tight.

This physical tension pulls on the trabecular meshwork, widening the spaces within it to improve the outflow of aqueous humor.

It's like pulling a tarp taut to smooth out the wrinkles and open up the weave.

That's a perfect analogy.

But these cholinergic drugs can have significant systemic side effects if they're absorbed.

We have a mnemonic for it.

S -L -D -G -E.

S -L -D -G -E.

That does not sound pleasant.

It's not.

It stands for salivation, lacrimation, urination, diarrhea, GI distress, and emesis or vomiting.

It's all the wet side effects.

Basically, everything starts flowing.

So palocarpine can essentially make you leak from everywhere if it gets into your system.

If the systemic absorption is high enough, yes.

It can also cause bradycardia, a dangerously slow heart rate.

Which brings us to class 3, beta -adrenergic blockers, timolol, betaxolol.

These are also extremely common.

They are, but they probably require the most vigilance from the nurse regarding systemic safety.

These drugs work on the faucet side of the equation.

They decrease the production of aqueous humor by the ciliary body.

But beta -blockers, as a class, are also very common heart and blood pressure medications.

And even though it is an eye drop, it can be absorbed systemically.

And this is where that concept of copicle does not mean local is absolutely critical.

The drop can drain down the tear duct into the nasal mucosa, which is highly vascular, and from there gets absorbed directly into the bloodstream, bypassing the liver's first -pass metabolism.

So if timolol gets into the blood, what happens?

The same thing that happens when you take an oral beta -blocker.

Ophthalmic beta -blockers can slow the heart rate bradycardia, they can worsen AV heart block, and they can exacerbate heart failure in susceptible patients.

And what about the lungs?

This is a huge point in the text.

A critical point.

Non -selective beta -blockers like timolol block both beta -1 receptors in the heart and beta -2 receptors in the lungs.

Blocking those beta -2 receptors can cause bronchoconstriction.

So an eye drop could trigger a full -blown asthma attack.

Yes.

Absolutely.

That is why they are contraindicated or must be used with extreme caution in patients with asthma or COPD.

This is a life or death safety check.

So how do we prevent this systemic absorption?

The text talks about a specific technique.

Yes.

Punctual occlusion.

It is non -negotiable when giving these drops.

Let's roleplay this.

I'm the nurse.

I have the bottle of timolol.

Walk me through it.

What do I do?

Okay.

You have the patient tilt their head back.

You gently pull down the lower eyelid to create a small pocket.

You instill one single drop into that conjunctival sac.

Immediately after the drop goes in, you take your glove finger and you press firmly on the inner cantus.

That's the corner of the eye right next to the nose.

And you hold that pressure for about two to three minutes.

What is that pressure physically doing?

You are pinching the nasal lacrimal duct.

The tear duct.

Shut.

You are physically preventing the drop from draining out of the eye into the nose and getting absorbed into the bloodstream.

It keeps the drug in the eye where we want it to work and out of the heart and lungs where it can do serious harm.

We will come back to a case study on this later, but that single simple technique sounds like it could be life -saving.

It absolutely is.

And it's our job to do it and to teach our patients to do it.

Okay.

Class four.

Alpha -adrenergic agonists.

Brahmonidine.

These are interesting because they do a bit of both.

They decrease production of aqueous humor and they improve outflow.

A key warning here is that they are absolutely contraindicated for persons taking monoamine oxybase inhibitor or MAOI therapy, as it can cause a hypertensive crisis.

Class five.

Carbonic and hydrase inhibitors.

CAIs.

Derozolamide is the drop, acetazolamide can be taken orally.

Carbonic and hydrase is an enzyme that's needed to produce aqueous humor.

So these drugs inhibit that enzyme.

They're essentially diuretics for the eye.

But the most important thing to remember is their chemical structure.

They're sulfonamides.

Sulfa drugs.

Yes.

So the first question you ask is, do you have a sulfa allergy?

Do not give these to patients with a known sulfa allergy.

That is a classic nursing safety check.

And finally, a newer class.

Roe kinase inhibitors.

Nature Sudil.

These work on the drain.

They increase aqueous humor outflow through the trabecular meshwork by relaxing the tissue.

They are often used as an add -on therapy when other drops aren't quite getting the pressure down low enough.

That is an incredibly comprehensive toolkit for glaucoma.

Let's shift our focus to the other sense, the ear, section six.

The ear is also divided into three sections, the external, the middle, and the inner ear.

External is the part we see, the pinna and the external auditory canal.

Correct.

This is where swimmer's ear or otitis externa happens.

It's basically an open channel leading to the eardrum.

The middle ear is behind the eardrum.

It has the tympanic membrane itself and those three tiny bones, the ossicles,

malleus, ensucs, and steades,

and the eustachian tube.

And this is where acute otitis media, AOM, the classic ear infection happens.

The eustachian tube connects the middle ear to the back of the throat.

The knee serinks to equalize pressure.

And that's the problem in kids, right?

It is.

In children, that tube is shorter, wider, and more horizontal than in adults, which is why they get so many more ear infections.

It just doesn't drain as well and bacteria can travel up it more easily.

And finally, the inner ear.

That's where the cochlea is for hearing and the vestibule and semicircular canals are for balance.

Let's talk about acute otitis media, AOM.

This is the classic childhood ear infection that every parent knows.

Yes.

It's an infection of the fluid that gets trapped in the middle ear space.

It often follows a cold or another upper respiratory infection.

Bacteria like streptococcus pneumonia or H influenza travel up that functional eustachian tube and start to multiply in the trapped fluid.

The text mentions a really positive trend, a decline in AOM cases linked to a vaccine.

Yes, the pneumococcal conjugate vaccine or PCV.

Since its introduction into the routine childhood vaccination schedule, there has been a significant decline in AOM caused by S pneumonia.

It's a fantastic example of preventative public health at work.

Then we have otitis externa, OE, swimmer's ear.

This is an infection of the skin of the canal itself.

Usually what happens is that moisture gets trapped in the canal from swimming or even just showering.

This alters the normal acidic pH and breaks down the protective layer of cerumen or earwax.

It makes the skin soggy.

It creates a soggy warm environment that's perfect for pathogens like Pseudomonas aeruginosa or Staphylococcus aureus to thrive.

Okay, moving to section seven, drugs for the ear.

How do we treat these two conditions differently?

Location determines the route.

For AOM, which is in the middle ear, topical ear drops usually can't reach the infection because the eardrum is in the way.

It's like trying to put out a fire in a sealed room by pouring water on the door.

So you have to go systemic.

You have to.

Oral amoxicillin is the gold standard, usually at a high dose.

If the patient is penicillin allergic, then maybe use ethromycin or clarithromycin.

But for otitis externa, which is in the outer ear canal, drops work just fine.

Exactly.

The infection is right there on the surface.

We use topical antibacterial drops.

Ciprofloxacin is a common one.

Or a combination drop like neomycin, polymycin, B hydrocortisone.

The hydrocortisone helps with the inflammation and itching.

There is a big contraindication warning in the text regarding that neomycin, polymycin, B combo drop.

A very important one.

Neomycin and polymycin B should not be used if the eardrum is perforated or if you can't visualize the eardrum to know for sure.

If there is a hole in the drum, the medication can leak into the inner ear and cause ototoxicity permanent damage to the hearing and balance cells.

So if you suspect a burst eardrum, what do you use instead?

The fluoroquinolone drops, like ciprofloxacin or ofloxacin, are generally considered safe to use even with a perforated eardrum.

They don't have that same ototoxic potential.

No.

What happens if the canal is so swollen from swimmer's ear that you can't even get a single drop in, it's just swollen shut?

That is extremely common and extremely painful.

In that case, we use something called the WIC method.

We take a piece of compressed cotton or sponge called a WIC and the provider gently inserts it into the swollen canal.

And then you put the drops on the WIC.

Exactly.

When you apply the drops to the outer part of the WIC, it expands like a sponge and it wicks the medication deep into the canal, holding it against the inflamed skin.

The WIC is usually left in for a day or two and then replaced.

Now, for what the text basically calls the great decongestant controversy, I feel like every parent has tried giving their kid antihistamines or decongestants when they have fluid in their ears or otitis media with effusion.

And we as healthcare professionals need to tell them to stop doing that.

The text is very firm on this, citing major evidence reviews.

Cochrane reviews and clinical guidelines state that antihistamines and decongestants are ineffective for clearing middle ear fluid.

So they just don't work?

They do not work.

They don't speed up recovery.

And the risks of side effects, drowsiness, irritability, palpitations in the child, far outweigh the non -existent benefits.

Our job as nurses is to educate patients against using over -the -counter cold meds for ear fluid.

Let's talk about earwax, sero -menelitics.

The most common one is carbamide peroxide.

It works by releasing oxygen, which helps to soften and break up impacted earwax.

And what about irrigation,

flushing the ear out?

This is a procedure nurses often do.

The critical, absolute number one safety point is the temperature of the water.

It must be warm body temperature.

Why is that so important?

If you use cold water, you will induce a vestibular reaction.

It's called a caloric response.

The cold temperature creates a convection current in the inner ear fluid that tells the brain you're spinning.

The patient will get severe vertigo, dizziness, and will likely vomit all over you.

So always use warm water?

Always, and the other rule is to never irrigate if you think the ear drum might because you'll just wash bacteria right into the middle ear and cause a nasty infection.

Okay, section eight, clinical judgment and nursing implications.

This is where we tie it all together.

It really starts with assessment.

You have to look at the whole patient, not just the eye or the ear.

You have to check for those contraindications.

Does the glaucoma patient have asthma?

If so, you need to question that Tmol order.

Does the patient needing acetazolamide have a sulfa allergy?

There is a case study in the text that highlights that beta blocker risk perfectly.

Yes, the 70 -year -old woman.

She has a history of glaucoma.

She comes into the clinic reporting new onset shortness of breath, dizziness, and weakness.

Her heart rate is down to 64, but it's irregular.

Her blood pressure is low, 100 over 62.

And when you look at her med list, you see she had just taken her drops.

Exactly, latanoprost and Tmolol.

The symptoms, the shortness of breath, the dizziness, the bradycardia, are classic signs of systemic beta blockade.

The nurse needs to connect those dots.

The eye drop caused the systemic heart and lung issues.

So the intervention isn't just check the heart.

No.

The intervention is teach puntal occlusion immediately.

And contact the prescriber to discuss switching medications.

Perhaps do something like betaxillol, which is more cardioselective.

Let's recap the other administration techniques.

We covered puntal occlusion for eyes.

What about the one drop rule?

The conjunctival sac, that little pocket inside the lower lid, can only physically hold about one drop of fluid.

If you put in two or three drops right after each other, the extra just spills out onto the cheek or increases the amount that goes down the tear duct for systemic absorption.

One drop is enough.

And if you have two different bottles of eye drops to use at the same time?

You have to wait five minutes between them.

If you put them in back to back, the second drop will just wash the first one out before it has a chance to be absorbed by the eye tissues.

What about the order of operations?

Drops then, ointments?

Always.

Drops first.

Ointments are greasy and create a barrier film over the eye.

If you put the ointment in first, the drops won't be able to penetrate it.

And for ears, there is a specific direction to pull the ear.

Yes.

This is to straighten out the S -shaped curve of the auditory canal so the drops can get all the way down to the eardrum.

For adults, you pull the pinna, UP, and BS.

For children under three years old, their canal is shaped differently, so you pull down and back.

Up for grown -ups, down for little ones?

That's the classic mnemonic.

And after you put the drops in, have the patient keep their head tilted for a minute or so so the drop doesn't just run right back out.

And finally, patient teaching.

This seems huge.

It's everything, especially in a chronic, asymptomatic disease like glaucoma.

It is a silent thief of sight.

Patients don't feel the high pressure, so when they feel fine, they might stop taking the drops.

We have to drive home the point that adherence is what prevents them from going blind.

In general safety?

Vision will be blurred after instilling drops or especially ointments.

They shouldn't be driving or operating machinery immediately after administration.

And any prevention tips for ear issues?

For swimmer's ear, using earplugs for swimming is a great idea.

And using a blow dryer on a low, cool setting held at a distance to gently dry the ears after swimming can really help prevent that skin maceration that leads to infection.

This has been a massive and I think incredibly important deep dive from the layers of the cornea to the risk of an asthma attack from a single eye drop.

It really highlights that the eye and the ear are not isolated islands.

They are intimately connected to the whole body and the drugs we use on them can affect everything.

So to wrap up, what is the one single thing you want our listener to walk away thinking about from this chapter?

I want them to have the phrase topical does not mean local, burned into their brain.

Just because you drop it in the eye or the ear doesn't mean it stays there.

As a nurse, you are the final safety barrier preventing a heart block from a glaucoma drop or an ototoxic reaction from an ear drop.

That is the essence of clinical judgment.

That's powerful stuff.

Thank you so much for guiding us through the pharmacology of the senses today.

It was my pleasure.

And to our listener, thank you for diving deep with us.

Keep questioning, keep learning, and we'll see you on the next deep dive.

This is the last minute lecture team signing off.